Prothena Corporation plc (PRTA)
NASDAQ: PRTA · Real-Time Price · USD
9.17
+0.08 (0.88%)
Feb 19, 2026, 3:16 PM EST - Market open
Prothena Corporation Market Cap
Prothena Corporation has a market cap or net worth of $493.62 million as of February 19, 2026. Its market cap has decreased by -31.74% in one year.
Market Cap
493.62M
Enterprise Value
165.94M
1-Year Change
-31.74%
Ranking
Category
Stock Price
$9.17
Market Cap Chart
Since December 21, 2012, Prothena Corporation's market cap has increased from $127.30M to $493.62M, an increase of 287.76%. That is a compound annual growth rate of 10.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 489.30M | -4.82% |
| Dec 31, 2025 | 514.10M | -31.02% |
| Dec 31, 2024 | 745.30M | -61.78% |
| Dec 29, 2023 | 1.95B | -33.09% |
| Dec 30, 2022 | 2.91B | 26.63% |
| Dec 31, 2021 | 2.30B | 380.02% |
| Dec 31, 2020 | 479.50M | -24.08% |
| Dec 31, 2019 | 631.60M | 53.82% |
| Dec 31, 2018 | 410.60M | -71.51% |
| Dec 29, 2017 | 1.44B | -15.04% |
| Dec 30, 2016 | 1.70B | -20.98% |
| Dec 31, 2015 | 2.15B | 277.66% |
| Dec 31, 2014 | 568.50M | -1.92% |
| Dec 31, 2013 | 579.60M | 347.22% |
| Dec 31, 2012 | 129.60M | 1.81% |
| Dec 21, 2012 | 127.30M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lyell Immunopharma | 518.14M |
| ADC Therapeutics | 511.61M |
| Allogene Therapeutics | 510.14M |
| Ginkgo Bioworks Holdings | 508.68M |
| Tenax Therapeutics | 507.13M |
| Gossamer Bio | 502.26M |
| Keros Therapeutics | 492.64M |
| Zevra Therapeutics | 486.97M |